Markets

Market Nav

INCOME STATEMENT

You can view the income statement for the last 5 years.
Torrent Pharmaceuticals Ltd.
( in Crs.)

ParticularsMar 25Mar 24Mar 23Mar 22Mar 21
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)ARARARARAR
FaceValue5.005.005.005.005.00
      
      
INCOME     
Revenue From Operations [Net]11317.2510562.319463.698418.807886.23
Other Operating Revenues198.84165.53156.4689.24118.34
Total Operating Revenues11516.0910727.849620.158508.048004.57
      
Other Income23.2757.9145.14196.5656.91
Total Revenue11539.3610785.759665.298704.608061.48
      
EXPENSES     
Cost Of Materials Consumed1520.321657.591480.421537.501420.69
Purchase Of Stock-In Trade1530.501183.631088.58830.651004.97
Changes In Inventories Of FG,WIP And Stock-In Trade-274.92-155.01166.1973.86-279.24
Employee Benefit Expenses2203.371984.401677.691526.451439.62
Finance Costs252.31353.56333.44255.06352.94
Depreciation And Amortisation Expenses794.93808.27706.59662.16657.79
Other Expenses2815.832689.582365.222108.311938.45
Total Expenses8842.348522.027818.136993.996535.22
      
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax2697.022263.731847.161710.611526.26
      
Exceptional Items-24.2188.380.00-484.700.00
Profit/Loss Before Tax2672.812352.111847.161225.911526.26
      
Tax Expenses-Continued Operations     
Current Tax619.01461.73354.77346.22334.08
Deferred Tax142.55234.00227.62106.53-52.98
Tax For Earlier Years0.000.0019.54-4.02-6.72
Total Tax Expenses761.56695.73601.93448.73274.38
Profit/Loss After Tax And Before ExtraOrdinary Items1911.251656.381245.23777.181251.88
      
Profit/Loss From Continuing Operations1911.251656.381245.23777.181251.88
      
Profit/Loss For The Period1911.251656.381245.23777.181251.88
Consolidated Profit/Loss After MI And Associates1911.251656.381245.23777.181251.88
      
OTHER INFORMATION     
      
EARNINGS PER SHARE     
Basic EPS (Rs.)56.4748.9436.7945.9373.98
Diluted EPS (Rs.)56.4748.9436.7945.9373.98
      
DIVIDEND AND DIVIDEND PERCENTAGE     
Equity Share Dividend1083.031015.34863.04676.89338.45
ParticularsMar 25
Months12
Source Of Info (AR = Annual Report, PR = Press Release)AR
FaceValue5.00
  
INCOME 
Revenue From Operations [Net]11317.25
Other Operating Revenues198.84
Total Operating Revenues11516.09
Other Income23.27
Total Revenue11539.36
EXPENSES 
Cost Of Materials Consumed1520.32
Purchase Of Stock-In Trade1530.50
Changes In Inventories Of FG,WIP And Stock-In Trade-274.92
Employee Benefit Expenses2203.37
Finance Costs252.31
Depreciation And Amortisation Expenses794.93
Other Expenses2815.83
Total Expenses8842.34
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax2697.02
Exceptional Items-24.21
Profit/Loss Before Tax2672.81
Tax Expenses-Continued Operations 
Current Tax619.01
Deferred Tax142.55
Tax For Earlier Years0.00
Total Tax Expenses761.56
Profit/Loss After Tax And Before ExtraOrdinary Items1911.25
Profit/Loss From Continuing Operations1911.25
Profit/Loss For The Period1911.25
Consolidated Profit/Loss After MI And Associates1911.25
OTHER INFORMATION 
EARNINGS PER SHARE 
Basic EPS (Rs.)56.47
Diluted EPS (Rs.)56.47
DIVIDEND AND DIVIDEND PERCENTAGE 
Equity Share Dividend1083.03